ArticleJAMA network open2021

Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.

Tomiko Oskotsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.